|View printer-friendly version|
Portola Announces Pricing of Public Offering of Common Stock
In addition, the company will not be presenting at the 2017
A registration statement relating to these securities has been filed with the
This announcement contains forward-looking statements, including statements relating to Portola Pharmaceuticals’ expectations regarding the completion, timing and size of the proposed public offering. These statements are subject to significant risks and uncertainties and actual results could differ materially from those projected.